✦ LIBER ✦

Akt1 Is a Potent Molecular Target for Treatment of Oral Cancer

✍ Scribed by Koh-ichi Nakashiro

Book ID: 113737473
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 38 KB
Volume: 65
Category: Article
ISSN: 1531-5053
DOI: 10.1016/j.joms.2007.06.218

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

103 Combination treatment of targeting S

103 Combination treatment of targeting Stat3 and HIF-1alpha is a potent strategy for prostate cancer therapy

✍ N. Jing; K.R. Reddy; Y.L. Guan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Chemical Carcinogenesis Models for Evalu

Chemical Carcinogenesis Models for Evaluating Molecular-Targeted Prevention and Treatment of Oral Cancer

✍ Vitale-Cross, L.; Czerninski, R.; Amornphimoltham, P.; Patel, V.; Molinolo, A. A 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 139 KB

TWIST1 is a molecular marker for a poor

TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target

✍ da Silva, Sabrina Daniela; Alaoui-Jamali, Moulay A.; Soares, Fernando Augusto; C 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 734 KB

265 Rac1 is a therapeutic target for pan

265 Rac1 is a therapeutic target for pancreatic cancer prevention and treatment

✍ C. Lubeseder-Martellato; I. Heid; B. Sipos; S. Rieder; R.M. Schmid; J.T. Siveke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Cyclooxygenase 2: a molecular target for

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

✍ Kotha Subbaramaiah; Andrew J. Dannenberg 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 513 KB

Combined targeting of MAPK and AKT signa

Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment

✍ F. Meier; S. Busch; K. Lasithiotakis; D. Kulms; C. Garbe; E. Maczey; M. Herlyn; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB